Jump to content

Atorolimumab: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').
Citation bot (talk | contribs)
Add: s2cid. | Use this bot. Report bugs. | Suggested by BorgQueen | Category:Chemicals that do not have a ChemSpider ID assigned | #UCB_Category 51/851
 
(8 intermediate revisions by 7 users not shown)
Line 1: Line 1:
{{short description|Chemical compound}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| Verifiedfields = changed
| verifiedrevid = 447728537
| verifiedrevid = 458639236
<!-- Monoclonal antibody data -->

<!--Monoclonal antibody data-->
| type = mab
| type = mab
| mab_type = mab
| mab_type = mab
| source = u
| source = u
| target = [[Rhesus blood group system|RhD]]
| target = [[Rhesus blood group system|RhD]]
<!-- Clinical data -->

| tradename =
<!--Clinical data-->
| tradename =
| pregnancy_AU =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_US =
| pregnancy_category =
| pregnancy_category =
| legal_AU =
| legal_AU =
| legal_CA =
| legal_CA =
| legal_UK =
| legal_UK =
| legal_US =
| legal_US =
| legal_status =
| routes_of_administration =
| legal_status =
<!-- Pharmacokinetic data -->
| routes_of_administration =
| bioavailability =

| protein_bound =
<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| protein_bound =
| metabolism =
| excretion =
<!-- Identifiers -->
| elimination_half-life =
| CAS_number_Ref = {{cascite|correct|CAS}}
| excretion =
| CAS_number = 202833-08-7

| UNII_Ref = {{fdacite|correct|FDA}}
<!--Identifiers-->
| UNII = ZT2TX7WZL7
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = <!-- blanked - oldvalue: 202833-08-7 -->
| ATC_prefix = none
| ATC_prefix = none
| ATC_suffix =
| ATC_suffix =
| PubChem =
| PubChem =
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = NA
| ChemSpiderID = none
<!-- Chemical data -->

| chemical_formula =
<!--Chemical data-->
| chemical_formula =
| molecular_weight =
| molecular_weight =
}}
}}
'''Atorolimumab''' is an [[immunosuppressive drug]] directed against the [[Rhesus factor]].<ref>[http://whqlibdoc.who.int/druginfo/INN_1999_list42.pdf WHO Drug Information]</ref>
'''Atorolimumab''' is an [[immunosuppressive drug]] directed against the [[Rhesus factor]].<ref>[http://whqlibdoc.who.int/druginfo/INN_1999_list42.pdf WHO Drug Information]</ref><ref>{{cite book | vauthors = Pelletier JP, Mukhtar F | chapter = Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies | veditors = Maitta RW |title=Immunologic Concepts in Transfusion Medicine |date=2020 |publisher=Elsevier |location=Philadelphia |isbn=978-0-323-67510-9 | doi = 10.1016/B978-0-323-67509-3.00016-0 |page=267 | s2cid = 213508934 }}</ref>


==References==
==References==
Line 56: Line 54:
{{monoclonal-antibody-stub}}
{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}
{{antineoplastic-drug-stub}}

[[it:Atorolimumab]]